Using high-resolution proteomic technologies, namely, nano-LC-MS/MS coupled to Orbitrap mass spectrometry, liver metastases of CRC revealing that the ECM is deregulated by cancer cell-derived peptidyl-arginine deiminase 4 (PAD4) were evaluated. Here, PADI4 is linked to colorectal carcinoma.